Should You Buy the Rally in Baytex Energy Corp. or Cameco Corp.?

Baytex Energy Corp. (TSX:BTE)(NYSE:BTE) and Cameco Corp. (TSX:CCO)(NYSE:CCJ) are trading at 12-month highs. Is this the right time to buy?

| More on:
Man holding magnifying glass over a document

Image source: Getty Images.

Baytex Energy Corp. (TSX:BTE)(NYSE:BTE) and Cameco Corp. (TSX:CCO)(NYSE:CCJ) are trading at 12-month highs, and investors are wondering if more gains could be on the way for these long-suffering stocks.

Let’s take a look at the current situation to see if Baytex and Cameco deserve to be in your portfolio.

Baytex

Baytex has surged from close to $3 per share in early March to $6. That’s an impressive move over such a short period of time, and the investors who had the foresight to get in at the recent lows are certainly patting themselves on the back today.

Drastic moves have been the name of the game for Baytex over the past two years. The stock bottomed out around $2 in early 2016 and has pretty much surged or tanked continuously since then on any signal in the market that oil could jump higher or reverse course.

The volatility is essentially due to the company’s debt level. When oil moves higher, investors feel more comfortable that Baytex can generate enough cash flow to chip away at the debt and boost the capital plan. The recent move in WTI oil above US$70 per barrel is certainly positive, and further gains could send Baytex even higher. The company has avoided a fire sale of its prized assets and has even estimated its net asset value to be above $9 per share at much lower oil prices.

Going back to the summer of 2014, Baytex was a $48 stock, so long-term investors might not be overly impressed with the recent move. However, the historical price is also an indication of how much upside potential there is if Baytex can find a way to wipe out its debt and significantly increase production.

Cameco

Cameco’s 35% surge in the past three months is a bit of a surprise. The company continues to struggle with low uranium prices, and there is little evidence to suggest the market is on the verge of a recovery.

At the time of writing, uranium spot prices are trending around US$22 per pound, which isn’t too far off the multi-year lows. To put things in perspective, uranium traded for US$70 per pound in early 2011, right before the tsunami hit Japan.

The Fukushima nuclear disaster forced Japan to close all of its nuclear reactors, and while the country is working hard to get the fleet back in service, progress is slow. According to a March report by World Nuclear News, seven of the country’s 42 operable reactors have received restart clearance.

Fans of Cameco say the stock could be a tightly coiled spring just waiting for the tide to turn in the uranium market. It’s true that annual uranium demand is expected to increase as much as 50% through 2030, and production cuts across the industry should eventually shift the supply balance.

For the moment, however, secondary supplies are filling demand gaps, and utilities are not rushing to sign up for new long-term supply agreements.

Cameco is also caught up in a battle with the Canada Revenue Agency (CRA) over taxes owed on earnings generated by a foreign subsidiary. If the company loses the case, the hit could be north of $2 billion.

Cameco’s annual guidance remained unchanged when it reported Q1 results, and there was no indication in the statement to indicate the uranium market is turning the corner.

Should you buy?

Both stocks continue to carry risk, so I wouldn’t back up the truck for either one.

That said, contrarian investors who think the oil recovery has legs might want to start a small position in Baytex.

Regarding Cameco, the recent rally might be connected to geopolitical noise or some short covering, but I wouldn’t chase it at this point. There simply isn’t any fundamental reason for buying the stock today, and a negative decision on the CRA case could send the share price back to the 2017 low.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Energy Stocks

Arrowings ascending on a chalkboard
Energy Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Canadian Natural Resources stock is well set up to beat the TSX as it continues to generate strong cash flows…

Read more »

energy industry
Energy Stocks

2 TSX Energy Stocks to Buy Hand Over Fist Now

These two rallying TSX energy stocks can continue delivering robust returns to investors in the long term.

Read more »

green energy
Energy Stocks

1 Magnificent TSX Dividend Stock Down 37% to Buy and Hold Forever

This dividend stock has fallen significantly from poor results, but zoom in and there are some major improvements happening.

Read more »

oil tank at night
Energy Stocks

3 Energy Stocks Already Worth Your While

Here's why blue-chip TSX energy stocks such as Enbridge should be part of your equity portfolio in 2024.

Read more »

Solar panels and windmills
Energy Stocks

1 Beaten-Down Stock That Could Be the Best Bet in the TSX

This renewable energy stock could be one of the best buys you make this year, as the company starts to…

Read more »

Dice engraved with the words buy and sell
Energy Stocks

Is Enbridge Stock a Buy, Sell, or Hold?

Here's why Enbridge (TSX:ENB) remains a top dividend stock long-term investors may want to consider, despite current risks.

Read more »

Gas pipelines
Energy Stocks

If You Had Invested $5,000 in Enbridge Stock in 2018, This Is How Much You Would Have Today

Enbridge's high dividend yield hasn't made up for its dismal total returns.

Read more »

Bad apple with good apples
Energy Stocks

Avoid at All Costs: This Stock Is Portfolio Poison

A mid-cap stock commits to return more to shareholders, but some investors remember the suspension of dividends a few years…

Read more »